Hildenia Balthazar Ribeiro Nogueira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hildenia Balthazar Ribeiro Nogueira has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Olivia Andrea Alencar Costa Bessa
Universidade de Fortaleza, Brazil
2 shared publications - Amália Maria Porto Lustosa1 shared publication
- Caroline Rolim Bezerra1 shared publication
- Claudia de Castro e Silva.
Serviço de Pneumologia Pediátrica, Hospital Infantil Albert Sabin - HIAS, Fortaleza (CE) Brasil
1 shared publication - Evalto Monte de Araújo Filho1 shared publication
- Janáira Fernandes Severo Ferreira
Department of Pediatric Allergy and Immunology Hospital Albert Sabin Fortaleza Brazil
1 shared publication
Latest Publications
- 8 September 2026
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Respiratory Research & Clinical Practice
Prevalence of the F508del variant in patients with cystic fibrosis in northeastern Brazil: clinical and laboratory factors
Objective: To describe the genetic profile of patients with cystic fibrosis in northeastern Brazil and correlate it with clinical and laboratory characteristics. Methods: This was a cross-sectional study, with descriptive and analytical elements, of patients followed during 2021 at a referral center for cystic fibrosis in the Brazilian state of Ceará. We analyzed pathogenic variants of genes that play a role in cystic fibrosis and their correlations with clinical variables (gender, age, weight, height, BMI, and nutritional status), laboratory variables (microbiology and sweat test results), and medications in use. Results: Of a total of 86 patients evaluated, 85 underwent genetic testing. Homozygous F508del mutations were identified in 60%, and 95% had a single F508del allele. Class IV or V mutations were seen in 4.6%. The majority of the mutations were in functional class I, II, or III. We found that a homozygous F508del mutation was significantly associated with BMI (p < 0.019), nutritional status (p < 0.03), and a positive sweat test result (p < 0.049), as well as identifying a significant association between the microbiology result and patient age (p < 0.001). Conclusions: In our sample, the proportion of patients who were homozygous for the F508del mutation was well above the national and international averages, which makes those patients potentially eligible for treatment with at least one CF transmembrane conductance regulator modulator. Keywords: Cystic fibrosis; Genotype; Phenotype; Prevalence.
- 8 September 2026
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Respiratory Research & Clinical Practice
Prevalence of the F508del variant in patients with cystic fibrosis in northeastern Brazil: clinical and laboratory factors
Objective: To describe the genetic profile of patients with cystic fibrosis in northeastern Brazil and correlate it with clinical and laboratory characteristics. Methods: This was a cross-sectional study, with descriptive and analytical elements, of patients followed during 2021 at a referral center for cystic fibrosis in the Brazilian state of Ceará. We analyzed pathogenic variants of genes that play a role in cystic fibrosis and their correlations with clinical variables (gender, age, weight, height, BMI, and nutritional status), laboratory variables (microbiology and sweat test results), and medications in use. Results: Of a total of 86 patients evaluated, 85 underwent genetic testing. Homozygous F508del mutations were identified in 60%, and 95% had a single F508del allele. Class IV or V mutations were seen in 4.6%. The majority of the mutations were in functional class I, II, or III. We found that a homozygous F508del mutation was significantly associated with BMI (p < 0.019), nutritional status (p < 0.03), and a positive sweat test result (p < 0.049), as well as identifying a significant association between the microbiology result and patient age (p < 0.001). Conclusions: In our sample, the proportion of patients who were homozygous for the F508del mutation was well above the national and international averages, which makes those patients potentially eligible for treatment with at least one CF transmembrane conductance regulator modulator. Keywords: Cystic fibrosis; Genotype; Phenotype; Prevalence.
- 5 April 2024
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 35 (4) , e14122
Autism in patients with eosinophilic gastrointestinal disease: A systematic review with meta‐analysis
Purpose: Neurodevelopmental disorders, such as autism spectrum disorder (ASD), have been increasingly associated with eosinophilic gastrointestinal disorders (EGID). However, the relationship between these diseases remains unclear. We performed a systematic review with meta‐analysis to address this issue.Methods: The search was performed according to the PRISMA guidelines using descriptors for ASD and EGIDs from the MEDLINE, Embase, PsycInfo, LILACS, and Web of Science databases. Observational studies with the prevalence of ASD in any EGID were included. The study protocol was registered on the PROSPERO platform under the number CRD42023455177.Results: The total dataset comprised 766,082 participants. The result of the single‐arm meta‐analysis showed an overall prevalence of ASD in the population with EGID of 21.59% (95% CI: 10.73–38.67). There was an association between EGID and ASD (OR: 3.44; 95% CI: 1.25–2.21), also significant when restricted only to EoE (OR: 3.70; 95% CI: 2.71–5.70).Discussion: Recent studies have implicated the influence of an inadequate epithelial barrier integrity in the pathogenesis of several diseases. The role of this mechanism can be extended to situations beyond allergic reactions, including other conditions with underlying immunological mechanisms. Several diseases are potentially related to the systemic effect of bacterial translocation in tissues with defective epithelial barriers.Conclusion: Our meta‐analysis provides evidence that supports the consideration of EGID in patients with ASD and ASD in patients with EGID. Despite its limitations, the results should also be validated by future studies, preferably using multicenter prospective designs in populations with low referral bias.
- 5 April 2024
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 35 (4) , e14122
Autism in patients with eosinophilic gastrointestinal disease: A systematic review with meta‐analysis
Purpose: Neurodevelopmental disorders, such as autism spectrum disorder (ASD), have been increasingly associated with eosinophilic gastrointestinal disorders (EGID). However, the relationship between these diseases remains unclear. We performed a systematic review with meta‐analysis to address this issue.Methods: The search was performed according to the PRISMA guidelines using descriptors for ASD and EGIDs from the MEDLINE, Embase, PsycInfo, LILACS, and Web of Science databases. Observational studies with the prevalence of ASD in any EGID were included. The study protocol was registered on the PROSPERO platform under the number CRD42023455177.Results: The total dataset comprised 766,082 participants. The result of the single‐arm meta‐analysis showed an overall prevalence of ASD in the population with EGID of 21.59% (95% CI: 10.73–38.67). There was an association between EGID and ASD (OR: 3.44; 95% CI: 1.25–2.21), also significant when restricted only to EoE (OR: 3.70; 95% CI: 2.71–5.70).Discussion: Recent studies have implicated the influence of an inadequate epithelial barrier integrity in the pathogenesis of several diseases. The role of this mechanism can be extended to situations beyond allergic reactions, including other conditions with underlying immunological mechanisms. Several diseases are potentially related to the systemic effect of bacterial translocation in tissues with defective epithelial barriers.Conclusion: Our meta‐analysis provides evidence that supports the consideration of EGID in patients with ASD and ASD in patients with EGID. Despite its limitations, the results should also be validated by future studies, preferably using multicenter prospective designs in populations with low referral bias.
- Open Access
- 4 May 2022
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 55 (1)
Fatores preditores do desfecho do Teste de Provocação Oral na Alergia à Proteína do Leite de Vaca: in natura vs. alimentos processados
Objetivos: Descrever uma população de crianças com alergia à proteína do leite de vaca (APLV) IgE mediada, submetidas ao teste de provocação oral (TPO) com alimentos processados vs. in natura, e comparar características clínico-epidemiológicas e laboratoriais, avaliando preditores de desfecho ao uso dessas diferentes apresentações de proteína. Métodos: Estudo transversal ambulatorial de alergia em hospital terciário em Fortaleza, Ceará. A coleta dos dados foi realizada entre outubro de 2018 a setembro de 2019. O questionário foi preenchido com os dados epidemiológicos, clínicos e laboratoriais encontrados no prontuário; amostra total de 49 crianças, com APLV IgE mediada tolerantes ao TPO com alimentos processados ou in natura. Resultados: Na comparação das características clinico-epidemiológicas das populações tolerantes a alimentos in natura vs. processados (respectivamente), a maioria apresentou dados semelhantes, como sexo masculino (60% vs. 57,9%), etnia parda (73,3% vs. 68,4%), idade gestacional a termo (80% vs. 77,8%), sem intercorrências durante a gestação (58,3% vs. 80,0%) ou parto (70% vs. 78,9), média de idade materna (32 anos vs. 35 anos), escolaridade materna (ensino médio completo - 43,3% vs. 47,4%), idade de início dos sintomas de APLV entre 1 e 6 meses (76,7% vs. 68,4%), aleitamento materno exclusivo entre 4 e 6 meses (60% vs. 68,45%), histórico de alergia familiar alimentar (73% vs. 68,4%), sendo as principais comorbidades alérgicas as respiratórias (38,9% vs. 35,7%) e alimentares (38,9% vs. 35,7%). Em relação aos dados laboratoriais, a maioria das frações de proteína no grupo tolerante a alimentos in natura e a alimentos processados apresentou valores ≤ 10 kU/L. Foi constatado que a idade materna (p = 0,006) e a idade de introdução de fórmula complementar (p = 0.020) se correlacionam de forma estatisticamente significante no grupo de pacientes tolerantes a alimentos processados. Conclusões: Foi observado que a idade materna (p = 0,006) e a idade de introdução de fórmula complementar (p=0.020) se correlacionam de forma estatisticamente significante no grupo de pacientes tolerantes alimentos processados. Os dados laboratoriais seguiram distribuição proporcionais entre os dois grupos, com maior frequência de valores ≤ 10 kU/L para todas as frações de proteína do leite de vaca, sem significância estatística. Estudos populacionais semelhantes em populações APLV IgE mediada são importantes caracterizando melhor esse fenótipo e otimizar ferramentas diagnósticas e protocolos de tratamento. Destaca-se também o papel da terapia baked, que auxilia na aquisição de tolerância a diferentes apresentações da PLV de forma mais breve, melhorando, portanto, a qualidade de vida desses pacientes.
- 4 May 2022
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 55 (1)
Open AccessFatores preditores do desfecho do Teste de Provocação Oral na Alergia à Proteína do Leite de Vaca: in natura vs. alimentos processados
Objetivos: Descrever uma população de crianças com alergia à proteína do leite de vaca (APLV) IgE mediada, submetidas ao teste de provocação oral (TPO) com alimentos processados vs. in natura, e comparar características clínico-epidemiológicas e laboratoriais, avaliando preditores de desfecho ao uso dessas diferentes apresentações de proteína. Métodos: Estudo transversal ambulatorial de alergia em hospital terciário em Fortaleza, Ceará. A coleta dos dados foi realizada entre outubro de 2018 a setembro de 2019. O questionário foi preenchido com os dados epidemiológicos, clínicos e laboratoriais encontrados no prontuário; amostra total de 49 crianças, com APLV IgE mediada tolerantes ao TPO com alimentos processados ou in natura. Resultados: Na comparação das características clinico-epidemiológicas das populações tolerantes a alimentos in natura vs. processados (respectivamente), a maioria apresentou dados semelhantes, como sexo masculino (60% vs. 57,9%), etnia parda (73,3% vs. 68,4%), idade gestacional a termo (80% vs. 77,8%), sem intercorrências durante a gestação (58,3% vs. 80,0%) ou parto (70% vs. 78,9), média de idade materna (32 anos vs. 35 anos), escolaridade materna (ensino médio completo - 43,3% vs. 47,4%), idade de início dos sintomas de APLV entre 1 e 6 meses (76,7% vs. 68,4%), aleitamento materno exclusivo entre 4 e 6 meses (60% vs. 68,45%), histórico de alergia familiar alimentar (73% vs. 68,4%), sendo as principais comorbidades alérgicas as respiratórias (38,9% vs. 35,7%) e alimentares (38,9% vs. 35,7%). Em relação aos dados laboratoriais, a maioria das frações de proteína no grupo tolerante a alimentos in natura e a alimentos processados apresentou valores ≤ 10 kU/L. Foi constatado que a idade materna (p = 0,006) e a idade de introdução de fórmula complementar (p = 0.020) se correlacionam de forma estatisticamente significante no grupo de pacientes tolerantes a alimentos processados. Conclusões: Foi observado que a idade materna (p = 0,006) e a idade de introdução de fórmula complementar (p=0.020) se correlacionam de forma estatisticamente significante no grupo de pacientes tolerantes alimentos processados. Os dados laboratoriais seguiram distribuição proporcionais entre os dois grupos, com maior frequência de valores ≤ 10 kU/L para todas as frações de proteína do leite de vaca, sem significância estatística. Estudos populacionais semelhantes em populações APLV IgE mediada são importantes caracterizando melhor esse fenótipo e otimizar ferramentas diagnósticas e protocolos de tratamento. Destaca-se também o papel da terapia baked, que auxilia na aquisição de tolerância a diferentes apresentações da PLV de forma mais breve, melhorando, portanto, a qualidade de vida desses pacientes.
- Open Access
- 17 July 2020
- Published by MedCrave Group Kft. in MOJ Anatomy & Physiology
- Vol. 7 (4) , 89-91
Eosinophilic esophagitis has association with the childbirth type
- 17 July 2020
- Published by MedCrave Group Kft. in MOJ Anatomy & Physiology
- Vol. 7 (4) , 89-91
Open AccessEosinophilic esophagitis has association with the childbirth type